A global diversified healthcare company and industry leader
Baxter International Inc. (NYSE:BAX), through its subsidiaries develops, manufactures and markets products that save and sustain lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2010 sales of $12.8 billion and has approximately 47,600 employees.
To learn more, click on Core Businesses.